Neutricks Trial Results Presented at The ACVB/AVSAB Veterinary Behavior Symposium

St. Louis, MO -- (July 15, 2011) Quincy Animal Health , a leader in canine cognitive health, is pleased to announce that Dr. Gary Landsberg, DVM, a board certified veterinary behaviorist and diplomate of the American College of Veterinary Behaviorists is presenting findings today on the cognitive effect of Neutricks in aged canines at the annual symposium of The American Veterinary Society of Animal Behavior in St. Louis.

Dr. Landsberg will present data from two different trials showing the effectiveness of Neutricks to help domains of cognitive function such as attention, learning, and recall in senior dogs. Even more significantly, Neutricks outperformed selegiline (Anipryl), the only approved medication for the control of clinical signs associated with canine cognitive dysfunction syndrome (CDS).

Key findings presented:

  • In an object discrimination test of aged beagles (greater than 9 years old), the Neutricks treated dogs showed significantly more accuracy in learning than the placebo-controlled treatment group.
  • The Neutricks beagles outperformed the control beagles in a task measuring attention using a visual search task with added distractors.
  • In the second study, the aged beagles in the Neutricks group showed more accurate learning and superior attention than the dogs in the selegiline arm.

“The research is exciting because it demonstrates a novel compound that can help animals afflicted with age-related cognitive difficulties and shows more promise than existing therapeutics which is especially important given the rising incidence of CDS,” said Quincy Animal Health President Mark Underwood.

Interested parties in reviewing the research can contact Quincy Animal Health .

About the ACVB/AVSAB

The American College of Veterinary Behaviorists (ACVB) and the American Veterinary Society of Animal Behavior (AVSAB) is a group of veterinarians and research professionals who share an interest in understanding behavior in animals. Founded in 1976, AVSAB is committed to improving the quality of life of all animals and strengthening the bond between animals and their owners.

About Quincy Animal Health

Quincy Animal Health, LLC markets Neutricks™, a new evidence-based chewable supplement for healthy brain aging in the canine senior wellness market. The product uses technology developed by parent company Quincy Bioscience, a biotechnology company based in Madison, Wisconsin. Quincy Bioscience is focused on the discovery, development and commercialization of novel compounds to fight the aging process. The company's products focus on restoring calcium balance related to neurodegenerative disorders and other destructive age-related mechanisms. www.quincyanimalhealth.com .

Media Contact:
Todd Olson
(608) 827-8134
tolson@quincybioscience.com

Tags:

About Us

Quincy Bioscience is a biotechnology company based in Madison, Wisconsin. Quincy Bioscience is focused on the discovery, development and commercialization of novel compounds to fight the aging process. The company's products focus on restoring calcium balance related to neurodegenerative disorders and other destructive age-related mechanisms.